The local immune response to intraocular Toxoplasma re-challenge: Less pathology and better parasite control through Treg/Th1/Th2 induction

International Journal for Parasitology

Volumn 43, Issue 9, 2013, Pages 721-728

  Sauer, Arnaud ^a,b   Rochet, Elise ^a   Lahmar, Ibtissem ^a,c   Brunet, Julie ^a   Sabou, Marcela ^a   Bourcier, Tristan ^b   Candolfi, Ermanno ^a   Pfaff, Alexander W ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Congenital toxoplasmosis; Inflammation; Ocular toxoplasmosis; Retina; T helper cell subsets; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 27; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

BIOASSAY; CYST; EXPERIMENTAL STUDY; IMMUNE RESPONSE; PARASITE; POLYMERASE CHAIN REACTION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CELLULAR IMMUNITY; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL MOUSE; EYE INFECTION; HOST PARASITE INTERACTION; INFLAMMATORY INFILTRATE; MOUSE; NEWBORN; NONHUMAN; PARASITE CONTROL; PARASITE VIRULENCE; PROTEOMICS; PROVOCATION TEST; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TH2 CELL; TOXOPLASMA GONDII; TRANSCRIPTION REGULATION;

CONGENITAL TOXOPLASMOSIS; INFLAMMATION; OCULAR TOXOPLASMOSIS; RETINA; T HELPER CELL SUBSETS; TOXOPLASMA GONDII;

ANIMALS; ANIMALS, NEWBORN; EYE DISEASES; MICE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

MUS; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84879880497     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2013.04.004     Document Type: Article

References (39)

1. Abou-Bacar A., Pfaff A.W., Letscher-Bru V., Filisetti D., Rajapakse R., Antoni E., Villard O., Klein J.P., Candolfi E. Role of gamma interferon and T cells in congenital Toxoplasma transmission. Parasite Immunol. 2004, 26:315-318.
2. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., Gery I., Lee Y.S., Egwuagu C.E. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 2007, 13:711-718.
3. Caspi R. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol. Res. 2008, 42:41-50.
4. Charles E., Joshi S., Ash J.D., Fox B.A., Farris A.D., Bzik D.J., Lang M.L., Blader I.J. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect. Immun. 2010, 78:3484-3492.
5. Delair E., Monnet D., Grabar S., Dupouy-Camet J., Yera H., Brezin A.P. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. Am. J. Ophthalmol. 2008, 146:851-855.
6. Diveu C., McGeachy M.J., Boniface K., Stumhofer J.S., Sathe M., Joyce-Shaikh B., Chen Y., Tato C.M., McClanahan T.K., de Waal Malefyt R., Hunter C.A., Cua D.J., Kastelein R.A. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 2009, 182:5748-5756.
7. Garweg J.G., Candolfi E. Immunopathology in ocular toxoplasmosis: facts and clues. Mem. Inst. Oswaldo Cruz 2009, 104:211-220.
8. Gavrilescu L.C., Butcher B.A., Del Rio L., Taylor G.A., Denkers E.Y. STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection. Infect. Immun. 2004, 72:1257-1264.
9. Gazzinelli R.T., Brezin A., Li Q., Nussenblatt R.B., Chan C.C. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp. Parasitol. 1994, 78:217-229.
10. Guiton R., Vasseur V., Charron S., Arias M.T., Van Langendonck N., Buzoni-Gatel D., Ryffel B., Dimier-Poisson I. Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. J. Infect. Dis. 2010, 202:427-435.
11. Hall A.O., Beiting D.P., Tato C., John B., Oldenhove G., Lombana C.G., Pritchard G.H., Silver J.S., Bouladoux N., Stumhofer J.S., Harris T.H., Grainger J., Wojno E.D., Wagage S., Roos D.S., Scott P., Turka L.A., Cherry S., Reiner S.L., Cua D., Belkaid Y., Elloso M.M., Hunter C.A. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 2012, 37:511-523.
12. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part I: Epidemiology and course of disease. Am. J. Ophthalmol. 2003, 136:973-988.
13. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part II: Disease manifestations and management. Am. J. Ophthalmol. 2004, 137:1-17.
14. Horie S., Sugita S., Futagami Y., Yamada Y., Mochizuki M. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells. Clin. Immunol. 2010, 136:83-95.
15. Hu M.S., Schwartzman J.D., Lepage A.C., Khan I.A., Kasper L.H. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation. Ocul. Immunol. Inflamm. 1999, 7:17-26.
16. Irmler I.M., Gajda M., Brauer R. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 2007, 179:6228-6236.
17. Jones L.A., Roberts F., Nickdel M.B., Brombacher F., McKenzie A.N., Henriquez F.L., Alexander J., Roberts C.W. IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur. J. Immunol. 2010, 40:426-436.
18. Kelly M.N., Kolls J.K., Happel K., Schwartzman J.D., Schwarzenberger P., Combe C., Moretto M., Khan I.A. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 2005, 73:617-621.
19. Kikumura A., Ishikawa T., Norose K. Kinetic analysis of cytokines, chemokines, chemokine receptors and adhesion molecules in murine ocular toxoplasmosis. Br. J. Ophthalmol. 2012, 96:1259-1267.
20. Kleinschek M.A., Owyang A.M., Joyce-Shaikh B., Langrish C.L., Chen Y., Gorman D.M., Blumenschein W.M., McClanahan T., Brombacher F., Hurst S.D., Kastelein R.A., Cua D.J. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 2007, 204:161-170.
21. Lahmar I., Guinard M., Sauer A., Marcellin L., Abdelrahman T., Roux M., Mousli M., Moussa A., Babba H., Pfaff A.W., Candolfi E. Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis. Exp. Parasitol. 2010, 124:190-196.
22. Letourneau S., Krieg C., Pantaleo G., Boyman O. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets. J. Allergy Clin. Immunol. 2009, 123:758-762.
23. McAuley J.B. Toxoplasmosis in children. Pediatr. Infect. Dis. J. 2008, 27:161-162.
24. Melzer T.C., Cranston H.J., Weiss L.M., Halonen S.K. Host cell preference of Toxoplasma gondii cysts in murine brain: a confocal study. J. Neuroparasitol. 2010, 1:N100505.
25. Newcomb D.C., Boswell M.G., Huckabee M.M., Goleniewska K., Dulek D.E., Reiss S., Lukacs N.W., Kolls J.K., Peebles R.S. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J. Immunol. 2012, 188:1027-1035.
26. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 2006, 7:354-359.
27. Parker S.J., Roberts C.W., Alexander J. CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immunol. 1991, 84:207-212.
28. Rosowski E.E., Lu D., Julien L., Rodda L., Gaiser R.A., Jensen K.D., Saeij J.P. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 2011, 208:195-212.
29. Saeij J.P., Coller S., Boyle J.P., Jerome M.E., White M.W., Boothroyd J.C. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 2007, 445:324-327.
30. Sauer A., Lahmar I., Scholler M., Villard O., Speeg-Schatz C., Brunet J., Pfaff A., Bourcier T., Candolfi E. Development of murine models of ocular toxoplasmosis and preliminary results of ocular inflammatory transcriptome. J. Fr. Ophtalmol. 2009, 32:742-749.
31. Sauer A., Pfaff A.W., Villard O., Creuzot-Garcher C., Dalle F., Chiquet C., Pelloux H., Speeg-Schatz C., Gaucher D., Prevost G., Bourcier T., Candolfi E. Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis. J. Infect. Dis. 2012, 206:1319-1329.
32. Streilein J.W. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 2003, 74:179-185.
33. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., Saris C.J., O'Shea J.J., Hennighausen L., Ernst M., Hunter C.A. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006, 7:937-945.
34. Sugita S., Horie S., Nakamura O., Futagami Y., Takase H., Keino H., Aburatani H., Katunuma N., Ishidoh K., Yamamoto Y., Mochizuki M. Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J. Immunol. 2008, 181:7525-7536.
35. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988, 240:516-518.
36. Villarino A.V., Stumhofer J.S., Saris C.J., Kastelein R.A., de Sauvage F.J., Hunter C.A. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 2006, 176:237-247.
37. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
38. Wojno E.D., Hunter C.A. New directions in the basic and translational biology of interleukin-27. Trends Immunol. 2012, 33:91-97.
39. Zhu J., Paul W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112:1557-1569.